These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 20528639)
1. Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice. Volpe M; Tocci G Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):811-20. PubMed ID: 20528639 [TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
3. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. Horký K Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167 [TBL] [Abstract][Full Text] [Related]
4. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492 [TBL] [Abstract][Full Text] [Related]
5. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension. White WB Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting the renin-angiotensin system: why and in which patients. Berra K; Miller NH J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897 [TBL] [Abstract][Full Text] [Related]
7. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy. Basile J; Neutel J Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hypertension in chronic kidney disease. Toto RD Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [TBL] [Abstract][Full Text] [Related]
14. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Abassi Z; Armaly Z; Nakhoul F; Hoffman A Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632 [TBL] [Abstract][Full Text] [Related]
15. Protecting renal function in the hypertensive patient: clinical guidelines. Bakris GL Am J Hypertens; 2005 Apr; 18(4 Pt 2):112S-119S. PubMed ID: 15837554 [TBL] [Abstract][Full Text] [Related]
16. The importance of sleep blood pressure. Morgan TO Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):803-9. PubMed ID: 20528638 [TBL] [Abstract][Full Text] [Related]
17. Recent changes in the landscape of combination RAS blockade. Epstein BJ; Smith SM; Choksi R Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020 [TBL] [Abstract][Full Text] [Related]
18. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner. Roberts ME; Epstein BJ J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098 [TBL] [Abstract][Full Text] [Related]
19. [Renal sequelae of sympathetic hyperactivity]. Watschinger B; Habicht A Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546 [No Abstract] [Full Text] [Related]
20. Blood pressure lowering only or more? Has the jury reached its verdict? Julius S Am J Cardiol; 2007 Aug; 100(3A):32J-37J. PubMed ID: 17666196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]